会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • Apparatus and method for model quality estimation and model adaptation in multivariable process control
    • 多变量过程控制中的模型质量估计和模型适应的装置和方法
    • US08560092B2
    • 2013-10-15
    • US12786052
    • 2010-05-24
    • Qingsheng Quinn ZhengHong Zhao
    • Qingsheng Quinn ZhengHong Zhao
    • G06F19/00
    • G05B13/048
    • Apparatuses and methods for model quality estimation and model adaptation in multivariable process control are disclosed. A method for updating a multiple input multiple output (MIMO) dynamical model of a process includes perturbing the process, auditing the controller model, identifying poor performing submodels and re-testing the relevant process variables, re-identifying submodels and adapting the model online while the process continues to operate within normal operating parameters. An apparatus comprises an online multivariable controller, a tester, a database to store data corresponding to manipulated variables and controlled variables, and a performance diagnosis module configured to identify problematic submodels and adapt a model used by the controller.
    • 公开了多变量过程控制中的模型质量估计和模型适应的装置和方法。 用于更新过程的多输入多输出(MIMO)动态模型的方法包括扰动过程,审核控制器模型,识别执行不良的子模型并重新测试相关过程变量,重新识别子模型并在线适配模型 该过程继续在正常操作参数内运行。 一种装置包括在线多变量控制器,测试器,用于存储与操作变量和受控变量相对应的数据的数据库,以及性能诊断模块,被配置为识别有问题的子模型并适应控制器使用的模型。
    • 14. 发明申请
    • Method for Managing Screen Orientation of a Portable Electronic Device
    • 便携式电子设备屏幕方向管理方法
    • US20130201219A1
    • 2013-08-08
    • US13368853
    • 2012-02-08
    • Hong ZhaoLieJun TaoDean E. Thorson
    • Hong ZhaoLieJun TaoDean E. Thorson
    • G09G5/00
    • G06F3/0346G06F1/1686G06F1/1694G06F3/012G06F3/013G06F2200/1614G06F2200/1637
    • There is described a portable electronic device capable of managing screen orientation. The portable electronic device comprises a display, a motion sensor, an image sensor and a processor. The display provides an image at a first orientation. The motion sensor attempts to detect a rotation of the portable electronic device. The image sensor attempts to detect one or more body features. The processor determines a second orientation of the image at the display based on the rotation detected at the motion sensor and/or the body feature or features detected at the image sensor. The portable electronic device may determine an orientation of the image at the display in response to detecting the rotation at the motion sensor and/or the body feature or features at the image sensor.
    • 描述了能够管理屏幕取向的便携式电子设备。 便携式电子设备包括显示器,运动传感器,图像传感器和处理器。 显示器以第一方向提供图像。 运动传感器尝试检测便携式电子设备的旋转。 图像传感器尝试检测一个或多个身体特征。 处理器基于在运动传感器处检测到的旋转和/或在图像传感器处检测到的身体特征或特征来确定图像在显示器处的第二取向。 响应于检测到运动传感器处的旋转和/或图像传感器处的身体特征或特征,便携式电子设备可以确定显示器处的图像的取向。
    • 19. 发明申请
    • Drug Repositioning Methods For Targeting Breast Tumor Initiating Cells
    • 用于靶向乳腺肿瘤起始细胞的药物重新定位方法
    • US20120296090A1
    • 2012-11-22
    • US13439626
    • 2012-04-04
    • Stephen TC WongHong ZhaoGuangxu Jin
    • Stephen TC WongHong ZhaoGuangxu Jin
    • G06F19/00C07D305/14C07C233/15C07D413/12
    • G16H50/50Y02A90/26
    • Disclosed are systems biology-based methods for repositioning known pharmaceutical compounds to new indications, through the identification of network-based signatures. In particular, the invention provides new and useful methods for selecting drugs or combinations of drugs (and preferably previously-approved drugs) for use in new therapeutic indications. Also disclosed are methods for identifying anti-breast tumor initiating cell (TIC)-based therapeutics from within populations of target compounds. In illustrative embodiments, the invention provides methods and computer programs for the repositioning of FDA-approved pharmaceutical compounds to new indications using network-based signature analysis coupled with conventional in vitro and in vivo testing of identified drug candidates. The invention also allows identification of drugs or drug combinations for treating unmet medical needs including, for example, “orphan” diseases.
    • 公开了基于系统生物学的方法,通过识别基于网络的签名将已知药物化合物重新定位到新的指示。 特别地,本发明提供用于选择用于新的治疗适应症的药物或药物组合(并优选先前认可的药物)的新的和有用的方法。 还公开了用于从目标化合物群体内鉴定抗乳腺肿瘤起始细胞(TIC)的治疗剂的方法。 在说明性实施例中,本发明提供了使用基于网络的签名分析与常规的体外和体内测定鉴定的候选药物来重新定位FDA批准的药物化合物到新的适应症的方法和计算机程序。 本发明还允许鉴定用于治疗未满足的医疗需要的药物或药物组合,包括例如孤儿疾病。